Join the QualityMetric science team for three presentations you won’t want to miss during this year’s ISOQOL Conference.    Development of Daily Diary Measures for Derivation of Endpoints in Clinical Trials Michelle White, Vice President, Consulting Science Services & Senior Scientist, QualityMetric will present: Wednesday, October 19th 10:30am-12:00pm (CEST) During the Industry Special Interest Group […]

In America alone, 25 million people are living with asthma—one of the most common and costly diseases with no cure.1 This respiratory condition can be accompanied by transient or chronic symptoms that significantly impact quality of life. In the past, healthcare providers approached asthma treatment by focusing on the severity of a patient’s asthma. With […]

The SF-36v2® and SF-12v2® Health Surveys are patient-reported outcome (PRO) assessments designed to measure the quality of life and functional health and well-being of patients across a variety of health conditions. With data from these robust questionnaires, researchers, investigators, providers and other healthcare professionals can factor in the voice of the patient as they conduct […]

Although the healthcare community has made significant progress in understanding its pathophysiology and developing beneficial treatments to manage it, asthma remains a common condition linked with high mortality and social and economic effects.1 The symptoms of asthma, from chest tightness and shortness of breath to coughing and wheezing, can impact the everyday life of those […]

Patient-centricity is paving a new path forward in the healthcare industry, changing the way we structure healthcare systems, deliver care and develop products. On a global scale, organizations are prioritizing the patient journey and shifting to value-based care as healthcare costs grow. These changes—along with other contributing factors—have placed a greater emphasis on outcome measurement.1 […]

RHODE ISLAND, February 21, 2022 ­­­— QualityMetric (QM), a technology-enabled provider of patient reported outcome (PRO) and clinical assessment outcome (COA) surveys, and consulting services, announced today the addition of Tim Burks as its newly-appointed Chief Technology Officer. Burks has joined the team led by Chief Executive Officer Garth “Gus” Gardner, who has been leading […]

Many fields in healthcare research benefit from leveraging clinician outcome assessments (COAs) to gain a deeper understanding of patient experiences. Patient-reported outcome (PRO) measures, or PROM, have seen an increased use over the years in clinical trials and other treatment delivery settings. These measurements paint a more complete picture of the spectrum of symptoms and […]

Health providers require flexible tools for calculating health-related quality of life (HRQoL) with precision—and life sciences companies need innovative tools to prove value in the product lifecycle. Instruments for accomplishing both goals aren’t always widely applicable, convenient, straightforward or fully responsive to the health changes patients experience. This is why organizations across the healthcare continuum […]

Rigorous and technical translation processes guide the development of content for a variety of products across the healthcare ecosystem. Patients, caregivers, clinicians, study site leaders and other key stakeholders rely on accurate information for research or care delivery in the pharmaceutical, biotechnology and medical device markets. Marketing finished endpoints, such as new drugs, therapies, treatment […]

Rhode Island — September 30, 2021 —QualityMetric, today announced a new partnership with Survivor Healthcare. The companies will be partnering to implement and measure an integrated program designed to improve cognitive functioning and overall health quality of life for cancer patients.

Clinician-reported outcome (ClinRO) measures are the gold standard for assessing patient experiences in clinical research. Over the years, routine care and clinical research have benefitted from incorporating data derived directly from real patient experiences through patient-reported outcome (PRO) measures, also known as PROMs. PRO instruments are increasingly valued in clinical trial settings and treatment delivery, […]

New York, September 14, 2021 — QualityMetric (QM), a leading global clinical outcomes assessments (COA) solutions provider and scientific consultancy specializing in patient-reported outcomes (PRO), has announced its collaboration  in ORCHESTRA, a three-year international research project led by the University of Verona to measure the impact of the SARS-CoV2 pandemic. The project involves thirty-seven total partners […]

QualityMetric and Pulse Infoframe announced today their partnership and vision to create the first scientifically validated rare disease instruments across conditions. Once deployed, these instruments will benefit not only rare disease patients and families, but also researchers and drug developers working to help this vastly underserviced population as they advance rare disease care and treatments.

Ms. Host’s distinguished career spans 20+ years, with progressively larger leadership roles in healthcare across life sciences, provider, and payer markets.

Mr. Hart will join the team led by Chief Executive Officer Garth “Gus” Gardner, who has been in that role since soon after the VSCP-led recapitalization of the company in August of 2020.

QualityMetric’s own Kimberly Raymond, Andrew Lovley, and Michelle White co-author a new study on the humanistic burden of hereditary transthyretin (hATTR) amyloidosis from the patient’s perspective.

QualityMetric’s Vice President and Senior Scientist, Mark Kosinski, co-authors a study for determining whether the content of the Asthma Control Test (ACT) serves as a valid measure of asthma control.

Our experts provide medical device clients with leading strategic measurement services, qualitative and quantitative research and patient journey studies, PRO outcomes analyses, rare disease research, and PRO regulatory support services.

As pharma, biotech, medical device companies and academic researchers race to discover treatments for COVID-19, they require measurement and outcomes reporting for capturing real-world evidence.

We want to inform you of a recent development that will allow us to enhance the services and support we provide.

Gardner’s appointment comes as the company seeks to build on its position as the preeminent provider of Patient Reported Outcomes (PRO) and Clinical Outcome Assessments (COA) solutions and services to healthcare and life sciences companies.